Oral Anti-Diabetic Drug
Global Oral Anti-Diabetic Drug Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
Report ID: BMRC 2130 | Number of pages: 195 | Publish Date: Jan 2020 | Category: Lifesciences and HealthcareLatest research report on Oral Anti-Diabetic Drug Market delivers a comprehensive study on current market trends. The outcome also includes revenue forecasts, statistics, market valuations which illustrates its growth trends and competitive landscape as well as the key players in the business.
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
This report studies the global market size of Oral Anti-Diabetic Drug in key regions like North America, Europe, China and Japan, focuses on the consumption of Oral Anti-Diabetic Drug in these regions.
This research report categorizes the global Oral Anti-Diabetic Drug market by top players/brands, region, type and end user. This report also studies the global Oral Anti-Diabetic Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Takeda
Pfizer
Eli Lilly
Janssen Pharmaceuticals
Astellas
Boehringer Ingelheim
Merck And Co.
AstraZeneca
Bristol Myers Squibb
Novartis
Sanofi
Abbott
Biocon
Oral Anti-Diabetic Drug market size by Type
Glimepiride
Gliclazide
Glyburide
Others
Oral Anti-Diabetic Drug market size by Applications
Hospital
Research Institual
Market size by Region
North America
United States
Canada
MexicoEurope
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Oral Anti-Diabetic Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Oral Anti-Diabetic Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Oral Anti-Diabetic Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Oral Anti-Diabetic Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
This report includes the estimation of market size for value (million US$) and volume (K Tons). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Oral Anti-Diabetic Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
Table of Content 1. Chapter - Report Methodology 1.1. Research Process 1.2. Primary Research 1.3. Secondary Research 1.4. Market Size Estimates 1.5. Data Triangulation 1.6. Forecast Model 1.7. USP’s of Report 1.8. Report Description 2. Chapter – Global Oral Anti-Diabetic Drug Market Overview: Qualitative Analysis 2.1. Market Introduction 2.2. Executive Summary 2.3. Global Oral Anti-Diabetic Drug Market Classification 2.4. Market Drivers 2.5. Market Restraints 2.6. Market Opportunity 2.7. Oral Anti-Diabetic Drug Market: Trends 2.8. Porter’s Five Forces Analysis 2.8.1. Bargaining Power of Suppliers 2.8.2. Bargaining Power of Consumers 2.8.3. Threat of New Entrants 2.8.4. Threat of Substitute Product and Services 2.8.5. Competitive Rivalry within the Industry 2.9. Market Attractiveness Analysis 2.9.1. Market Attractiveness Analysis by Segmentation 2.9.2. Market Attractiveness Analysis by Region 3. Chapter - Global Oral Anti-Diabetic Drug Market Overview: Quantitative Analysis 3.1. Global Oral Anti-Diabetic Drug Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025 3.2. Global Oral Anti-Diabetic Drug Market Revenue Market Share (%), 2014- 2025 3.3. Global Oral Anti-Diabetic Drug Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025 3.4. Global Oral Anti-Diabetic Drug Market Sales Market Share (%), 2014- 2025 4. Chapter – Global Oral Anti-Diabetic Drug Market Analysis: Segmentation By Type 5. Chapter – Global Oral Anti-Diabetic Drug Market Analysis: Segmentation By Application 6. Chapter - Global Oral Anti-Diabetic Drug Market Analysis: By Manufacturer 6.1. Global Oral Anti-Diabetic Drug Market Revenue (USD Million), by Manufacturer, 2014 - 2025 6.2. Global Oral Anti-Diabetic Drug Market Share (%), by Manufacturer, 2018 6.3. Global Oral Anti-Diabetic Drug Market Sales (Number of Units), by Manufacturer, 2014 - 2025 6.4. Global Oral Anti-Diabetic Drug Market Share (%), by Manufacturer, 2018 6.5. Global Oral Anti-Diabetic Drug Market Price (USD/Unit), by Manufacturer, 2014 - 2025 6.6. Global Oral Anti-Diabetic Drug Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025 6.7. Merger & Acquisition 6.8. Collaborations and Partnership 6.9. New Product Launch 7. Chapter –Oral Anti-Diabetic Drug Market: Regional Analysis 7.1. North America 7.1.1. North America Oral Anti-Diabetic Drug Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025. 7.1.2. North America Oral Anti-Diabetic Drug Market Revenue (USD Million) By Country, 2014 – 2025. 7.1.3. North America Oral Anti-Diabetic Drug Revenue Market Share (%) By Country, 2014 – 2025. 7.1.4. North America Oral Anti-Diabetic Drug Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.1.5. North America Oral Anti-Diabetic Drug Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.1.6. North America Oral Anti-Diabetic Drug Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025. 7.1.7. North America Oral Anti-Diabetic Drug Market Sales (Number of Units) By Country, 2014 – 2025. 7.1.8. North America Oral Anti-Diabetic Drug Sales Market Share (%) By Country, 2014 – 2025. 7.1.9. North America Oral Anti-Diabetic Drug Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.1.10. North America Oral Anti-Diabetic Drug Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.2. Europe 7.3. Asia Pacific 7.4. Latin America 7.5. Middle East & Africa 8. Chapter - Company Profiles